Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing
Earnings Per Share AnalysisEarnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
About Earnings Per ShareEarnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.
|Compare to competition|
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd has Earnings Per Share of -1.24 times. This is much lower than that of the sector, and significantly lower than that of Earnings Per Share industry, The Earnings Per Share for all stocks is over 1000% higher than the company.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is rated fourth in current ratio category among related companies. It is rated below average in current valuation category among related companies reporting about 510,355,030 of Current Valuation per Current Ratio.